Bloomberg reported:
Carlyle Group Inc. is in advanced discussions to invest in Resonetics, a health-care asset owned by fellow private equity firm GTCR, according to people familiar with the matter. Carlyle is in talks to buy half of Resonetics in a deal that will value the medical-device manufacturing company at about $2.3 billion, including debt.
The Carlyle Group's last healthcare deal with GTCR turned out poorly for Lifecare Hospital patients and staff in New Orleans post Hurricane Katrina. Carlyle steered LifeCare into bankruptcy after .
Job exporter Carlyle is at it again. PRNewswire stated:
Resonetics To Add Second Production Facility In Costa Rica
Resonetics announced today it has leased new manufacturing space in a building a short distance from its current site in the Coyol Free Zone in Alajuela, Costa Rica. The space will be expanded and reconfigured to create a 45,000 square foot production site. The expansion will more than double Resonetics' capacity in Costa Rica following the additions made to its existing site in 2020.
That news came in April 2021.
Carlyle is part of a consortium buying giant medical supplier. Medline. Most U.S. medical supplies are made in China. When that system failed people died in the United States.
The greed and leverage boys are obsessed with profits and tax avoidance. Employees are a cost input to be manipulated.
The more healthcare companies are purchased by private equity underwriters (PEU), the more expensive becomes our absurdly high-cost healthcare system. Remember PEU generated surprise medical billing? Please make it all stop.
